Sharafat Hussain: Understanding CD Markers in Modern Cancer Therapy
Sharafat Hussain, Zonal Sales Manager (North) Oncology at Revive Healthcare International, shared a post on LinkedIn: ”What Does ‘CD’ Mean in Oncology? Understanding the Language Behind Targeted…
Read the full articleYou might also wanna read
<![CDATA[19 Targeted Axillary Dissection—Does the Biopsy-Proven Node Need to Be Localized? A Retrospective Review of Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy]]>
Researchers identify biological markers of treatment-resistant aggressive lymphoma
Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lympho
news-medical.net·5d agoPromoting Response to IMmunotherapy by Exercise in Patients With Advanced Renal Cell Carcinoma
Conditions : Oncology Interventions : Behavioral: HIIT Sponsors : Radboud University Medical Center Not yet recruiting
CAR T Revolutionized How We Treat Blood Cancers. Now It’s Closing In on Solid Tumors.
Separate teams discovered the same target in solid cancers, enabling a powerful two-pronged attack on both tumors and the cells shielding th
Medscape and IMF Partnership: Panel Discussion on CD38-Targeted Therapy for Multiple Myeloma
From tailored quadruplet regimens to innovative delivery systems, discover the patient-centric future of multiple myeloma treatment.
mdsc.pe·1d agoWearable Data for Personalized Prognostication in Cancer: A Registry Protocol
Conditions : Hematopoietic Neoplasm; Malignant Solid Neoplasm; Lymphatic System Neoplasm; Hematopoietic and Lymphatic System Neoplasm Interv
Comments
Sign in to join the conversation.
No comments yet. Be the first.